☰

Tanuja Chitnis, M.D.

Affiliations: 
Neurology Harvard Medical School and Brigham and Women Hospital, Boston, MA, United States 
Area:
Multiple Sclerosis, Pediatric Multiple Sclerosis, Natural History
Website:
https://connects.catalyst.harvard.edu/profiles/profile/person/36152
Google:
"Tanuja Chitnis"
Mean distance: 18.73 (cluster 56)
 
Cross-listing: History of History Tree

Tree Publications Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

Parents

Sign in to add mentor
Samia Joseph Khoury post-doc Harvard Medical School and Brigham and Women Hospital

Children

Sign in to add trainee
Taha Gholipour post-doc 2010-2013 Harvard Medical School and Brigham and Women Hospital

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zeng L, Atlas K, Lama T, et al. (2024) GWAS highlights the neuronal contribution to multiple sclerosis susceptibility. Medrxiv : the Preprint Server For Health Sciences
Madill E, Healy BC, Molazadeh N, et al. (2024) Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis. Annals of Clinical and Translational Neurology
Saucier L, Healy BC, Saxena S, et al. (2024) Glial fibrillary acidic protein and neurofilament light chain as biomarkers in pediatric multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 10: 20552173241274567
Jensen SKG, Camposano S, Berens A, et al. (2024) Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study. Neurology(R) Neuroimmunology & Neuroinflammation. 11: e200282
Mohan SD, Peterson S, Brenton JN, et al. (2024) Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 30: 1056-1065
Manzano GS, Levy M, Salky R, et al. (2024) Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes. Journal of Neurology
Nasr Z, Casper TC, Waltz M, et al. (2024) Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Multiple Sclerosis and Related Disorders. 87: 105647
Chitnis T, Qureshi F, Gehman VM, et al. (2024) Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis. Nature Communications. 15: 4297
Airas L, Bermel RA, Chitnis T, et al. (2024) A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis. Therapeutic Advances in Neurological Disorders. 17: 17562864241233041
Singhal T, Cicero S, Rissanen E, et al. (2024) Glial Activity Load on PET Reveals Persistent "Smoldering" Inflammation in MS Despite Disease-Modifying Treatment: 18F-PBR06 Study. Clinical Nuclear Medicine
See more...